Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer.


Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
15 08 2019
Historique:
received: 17 01 2019
revised: 15 04 2019
accepted: 23 05 2019
pubmed: 31 5 2019
medline: 20 8 2020
entrez: 31 5 2019
Statut: ppublish

Résumé

In research settings, circulating tumor DNA (ctDNA) shows promise as a tumor-specific biomarker for pancreatic ductal adenocarcinoma (PDAC). This study aims to perform analytical and clinical validation of a Digital-droplet PCR was used to detect the major PDAC-associated somatic ctDNA was detected preoperatively in 29 (49%) patients and was an independent predictor of decreased recurrence-free survival (RFS) and overall survival (OS). Patients who had neoadjuvant chemotherapy were less likely to have preoperative ctDNA than were chemo-naïve patients (21% vs. 69%; Measurement of

Identifiants

pubmed: 31142500
pii: 1078-0432.CCR-19-0197
doi: 10.1158/1078-0432.CCR-19-0197
pmc: PMC7403524
mid: NIHMS1609811
doi:

Substances chimiques

Biomarkers, Tumor 0
Circulating Tumor DNA 0
KRAS protein, human 0
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4973-4984

Subventions

Organisme : NCI NIH HHS
ID : P30 CA006973
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA062924
Pays : United States

Informations de copyright

©2019 American Association for Cancer Research.

Références

Br J Cancer. 2016 Jun 28;115(1):59-65
pubmed: 27280632
N Engl J Med. 2013 Mar 28;368(13):1199-209
pubmed: 23484797
HPB (Oxford). 2018 Apr;20(4):297-304
pubmed: 29366815
Fam Cancer. 2015 Mar;14(1):95-103
pubmed: 25240578
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
J Clin Oncol. 2018 Jun 1;36(16):1631-1641
pubmed: 29504847
Cancer Res. 1987 Oct 15;47(20):5501-3
pubmed: 3308077
Cochrane Database Syst Rev. 2018 Mar 20;3:CD011044
pubmed: 29557103
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Clin Chem. 2017 Mar;63(3):691-699
pubmed: 28073896
Br J Surg. 2018 Jul;105(8):946-958
pubmed: 29708592
Nature. 2017 Apr 26;545(7655):446-451
pubmed: 28445469
Nat Med. 2008 Sep;14(9):985-90
pubmed: 18670422
Curr Mol Med. 2013 Mar;13(3):340-51
pubmed: 23331006
Ann Surg. 2019 Jun;269(6):1154-1162
pubmed: 31082915
Mol Diagn Ther. 2014 Oct;18(5):587-93
pubmed: 25091469
J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061
pubmed: 28784865
Clin Cancer Res. 2018 May 15;24(10):2241-2250
pubmed: 29269376
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9530-5
pubmed: 21586637
JAMA Oncol. 2018 Mar 8;4(3):e173420
pubmed: 29098284
Sci Transl Med. 2016 Jul 6;8(346):346ra92
pubmed: 27384348
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Lancet. 2017 Mar 11;389(10073):1011-1024
pubmed: 28129987
J Natl Cancer Inst. 2018 Aug 1;110(8):803-811
pubmed: 29873743
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Science. 2018 Sep 7;361(6406):1033-1037
pubmed: 30190408
CA Cancer J Clin. 2013 Sep;63(5):318-48
pubmed: 23856911
Am J Clin Pathol. 2014 Jun;141(6):856-66
pubmed: 24838331
Ann Oncol. 2018 Apr 1;29(4):1016-1022
pubmed: 29562308
Nat Med. 2015 Jul;21(7):795-801
pubmed: 26030179
JAMA. 2017 Oct 3;318(13):1272-1274
pubmed: 28973237
Gut. 2019 Apr;68(4):663-671
pubmed: 29420226
Ann Surg. 2018 May;267(5):936-945
pubmed: 28338509
Ann Surg Oncol. 2018 Aug;25(8):2475-2483
pubmed: 29948425
Mol Cancer Ther. 2019 Jan;18(1):196-203
pubmed: 30301865
N Engl J Med. 2018 Nov 01;379(18):1754-1765
pubmed: 30380390
Ann Oncol. 2015 Aug;26(8):1715-22
pubmed: 25851626
Ann Surg. 2018 Sep;268(3):408-420
pubmed: 30080739
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
Eur J Surg Oncol. 2016 Oct;42(10):1552-60
pubmed: 27570116
N Engl J Med. 2018 Dec 20;379(25):2395-2406
pubmed: 30575490
Int J Cancer. 2017 May 15;140(10):2344-2350
pubmed: 28205231
Ann Surg. 2018 Jul;268(1):9-10
pubmed: 29578913
Clin Cancer Res. 2015 Jul 15;21(14):3196-203
pubmed: 25829397
Science. 2008 Sep 26;321(5897):1801-6
pubmed: 18772397
Nat Commun. 2015 Jul 07;6:7686
pubmed: 26154128
Anal Chem. 2011 Nov 15;83(22):8604-10
pubmed: 22035192
N Engl J Med. 2013 Oct 31;369(18):1691-703
pubmed: 24131140
Eur J Radiol. 2018 Sep;106:128-136
pubmed: 30150034
Gastroenterology. 2019 Jan;156(1):108-118.e4
pubmed: 30240661
Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):394-403
pubmed: 28801248

Auteurs

Vincent P Groot (VP)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Surgery, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.

Stacy Mosier (S)

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Molecular Pathology Laboratory, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Ammar A Javed (AA)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Jonathan A Teinor (JA)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Georgios Gemenetzis (G)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Ding Ding (D)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
The Pancreatic Cancer Precision Medicine Center of Excellence Program, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Lisa M Haley (LM)

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Molecular Pathology Laboratory, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Jun Yu (J)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Richard A Burkhart (RA)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Alina Hasanain (A)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Marija Debeljak (M)

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Molecular Pathology Laboratory, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Hirohiko Kamiyama (H)

Department of Gastroenterological Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Amol Narang (A)

Department of Radiation Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Daniel A Laheru (DA)

Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Lei Zheng (L)

Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
The Pancreatic Cancer Precision Medicine Center of Excellence Program, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Ming-Tseh Lin (MT)

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Molecular Pathology Laboratory, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Christopher D Gocke (CD)

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Molecular Pathology Laboratory, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Elliot K Fishman (EK)

Department of Radiology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Ralph H Hruban (RH)

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Michael G Goggins (MG)

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

I Quintus Molenaar (IQ)

Department of Surgery, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.

John L Cameron (JL)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Matthew J Weiss (MJ)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Victor E Velculescu (VE)

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Jin He (J)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Christopher L Wolfgang (CL)

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

James R Eshleman (JR)

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland. jeshlem@jhmi.edu.
Molecular Pathology Laboratory, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH